CVS Health Co. (NYSE:CVS) EVP Lisa Bisaccia sold 25,177 shares of the company’s stock in a transaction on Tuesday, January 12th. The shares were sold at an average price of $77.00, for a total transaction of $1,938,629.00. Following the completion of the sale, the executive vice president now owns 71,765 shares of the company’s stock, valued at approximately $5,525,905. The transaction was disclosed in a filing with the SEC, which can be accessed through this link.

CVS Health stock opened at $74.92 on Thursday. The firm has a 50-day moving average of $70.55 and a 200-day moving average of $64.33. CVS Health Co. has a one year low of $52.04 and a one year high of $77.23. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.95 and a quick ratio of 0.67. The company has a market cap of $98.06 billion, a price-to-earnings ratio of 12.38, a P/E/G ratio of 1.69 and a beta of 0.82.

CVS Health (NYSE:CVS) last issued its earnings results on Wednesday, November 11th. The pharmacy operator reported $1.66 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.33 by $0.33. CVS Health had a net margin of 2.99% and a return on equity of 15.60%. The business had revenue of $67.05 billion during the quarter, compared to the consensus estimate of $66.54 billion. During the same period last year, the business posted $1.84 EPS. CVS Health’s revenue was up 3.5% on a year-over-year basis. As a group, sell-side analysts expect that CVS Health Co. will post 7.43 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Monday, February 1st. Investors of record on Friday, January 22nd will be paid a $0.50 dividend. The ex-dividend date of this dividend is Thursday, January 21st. This represents a $2.00 annualized dividend and a yield of 2.67%. CVS Health’s dividend payout ratio (DPR) is currently 28.25%.

A number of research firms recently commented on CVS. Cantor Fitzgerald restated an “overweight” rating on shares of CVS Health in a research report on Monday, November 9th. Piper Sandler upped their price objective on shares of CVS Health from $72.00 to $76.00 and gave the company an “overweight” rating in a research report on Wednesday, November 11th. BidaskClub upgraded shares of CVS Health from a “hold” rating to a “buy” rating in a research report on Thursday, January 7th. Deutsche Bank Aktiengesellschaft lowered their target price on CVS Health from $104.00 to $101.00 and set a “buy” rating for the company in a report on Monday, November 9th. Finally, Jefferies Financial Group upgraded CVS Health from a “hold” rating to a “buy” rating and set a $90.00 target price for the company in a report on Friday, January 8th. One analyst has rated the stock with a sell rating, three have given a hold rating, thirteen have assigned a buy rating and one has issued a strong buy rating to the company. CVS Health has a consensus rating of “Buy” and an average price target of $82.93.

Large investors have recently modified their holdings of the stock. Formidable Asset Management LLC lifted its stake in CVS Health by 9.3% in the 3rd quarter. Formidable Asset Management LLC now owns 17,767 shares of the pharmacy operator’s stock valued at $1,029,000 after purchasing an additional 1,506 shares during the last quarter. Van ECK Associates Corp lifted its stake in CVS Health by 16.6% in the 3rd quarter. Van ECK Associates Corp now owns 161,529 shares of the pharmacy operator’s stock valued at $9,433,000 after purchasing an additional 23,005 shares during the last quarter. Perkins Coie Trust Co lifted its stake in CVS Health by 2.8% in the 4th quarter. Perkins Coie Trust Co now owns 41,512 shares of the pharmacy operator’s stock valued at $2,835,000 after purchasing an additional 1,141 shares during the last quarter. Butensky & Cohen Financial Security Inc. lifted its stake in CVS Health by 11.7% in the 4th quarter. Butensky & Cohen Financial Security Inc. now owns 49,203 shares of the pharmacy operator’s stock valued at $3,361,000 after purchasing an additional 5,145 shares during the last quarter. Finally, First Citizens Bank & Trust Co. lifted its stake in CVS Health by 5.9% in the 4th quarter. First Citizens Bank & Trust Co. now owns 34,073 shares of the pharmacy operator’s stock valued at $2,328,000 after purchasing an additional 1,904 shares during the last quarter. Institutional investors and hedge funds own 74.21% of the company’s stock.

About CVS Health

CVS Health Corporation provides health services and plans in the United States. The company's Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services.

Recommended Story: What is a growth and income fund?

Insider Buying and Selling by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.